Skip to main content

Magnesium Intake, Genetic Variants, and Diabetes Risk

  • Chapter
  • First Online:
Magnesium in Human Health and Disease

Abstract

Type 2 diabetes mellitus (DM) is a major global public health burden, affecting more than 170 million individuals worldwide [1]. Overall, it is estimated that the prevalence of diabetes will increase by 42 % among adults living in developed countries and by 170 % among adults in developing countries by 2025 [2, 3]. More alarmingly, by the time type 2 DM is diagnosed, most individuals have developed complications such as peripheral artery disease, renal failure, and neuropathy, and the vast majority of diabetic patients die of these complications [4]. Given the rising global burden of type 2 DM and its devastating complications, there is a great urgency to develop effective strategies to curb the epidemic by identifying individuals at high risk and optimizing prevention and early treatment. The predisposition to type 2 DM varies widely in the population and is largely determined by complex gene–environment interactions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

Type 2 DM:

Type 2 diabetes mellitus

TRPM6:

Transient receptor potential membrane melastatin 6

TRPM7:

Transient receptor potential membrane melastatin 7

PLCN-1:

Paracellin-1

SLC41A1:

Solute carrier family 41 member 1

MRS2:

Mitochondrial RNA splicing 2

FXYD2:

Sodium-potassium-ATPase, gamma-1 polypeptide

SLC12A3:

Solute carrier family 12 (sodium/chloride transporter)

References

  1. Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet. 2005;365:1333–46.

    Article  PubMed  CAS  Google Scholar 

  2. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414–31.

    Article  PubMed  CAS  Google Scholar 

  3. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–53.

    Article  PubMed  Google Scholar 

  4. Nathan DM. Long-term complications of diabetes mellitus. N Engl J Med. 1993;328:1676–85.

    Article  PubMed  CAS  Google Scholar 

  5. Ford ES, Mokdad AH. Dietary magnesium intake in a national sample of us adults. J Nutr. 2003;133:2879–82.

    PubMed  CAS  Google Scholar 

  6. Vaquero MP. Magnesium and trace elements in the elderly: intake, status and recommendations. J Nutr Health Aging. 2002;6:147–53.

    PubMed  CAS  Google Scholar 

  7. Saris NE, Mervaala E, Karppanen H, Khawaja JA, Lewenstam A. Magnesium. An update on physiological, clinical and analytical aspects. Clin Chim Acta. 2000;294:1–26.

    Article  PubMed  CAS  Google Scholar 

  8. Fung TT, Manson JE, Solomon CG, Liu S, Willett WC, Hu FB. The association between magnesium intake and fasting insulin concentration in healthy middle-aged women. J Am Coll Nutr. 2003;22:533–8.

    PubMed  CAS  Google Scholar 

  9. Song Y, Ridker PM, Manson JE, Cook NR, Buring JE, Liu S. Magnesium intake, c-reactive protein, and the prevalence of metabolic syndrome in middle-aged and older U.S. Women. Diabetes Care. 2005;28:1438–44.

    Article  PubMed  CAS  Google Scholar 

  10. He K, Liu K, Daviglus ML, Morris SJ, Loria CM, Van Horn L, et al. Magnesium intake and incidence of metabolic syndrome among young adults. Circulation. 2006;113:1675–82.

    Article  PubMed  CAS  Google Scholar 

  11. Colditz GA, Manson JE, Stampfer MJ, Rosner B, Willett WC, Speizer FE. Diet and risk of clinical diabetes in women. Am J Clin Nutr. 1992;55:1018–23.

    PubMed  CAS  Google Scholar 

  12. Salmeron J, Ascherio A, Rimm EB, Colditz GA, Spiegelman D, Jenkins DJ, et al. Dietary fiber, glycemic load, and risk of NIDDM in men. Diabetes Care. 1997;20:545–50.

    Article  PubMed  CAS  Google Scholar 

  13. Song Y, Manson JE, Buring JE, Liu S. Dietary magnesium intake in relation to plasma insulin levels and risk of type 2 diabetes in women. Diabetes Care. 2004;27:59–65.

    Article  PubMed  Google Scholar 

  14. Abbott RD, Ando F, Masaki KH, Tung KH, Rodriguez BL, Petrovitch H, et al. Dietary magnesium intake and the future risk of coronary heart disease (the Honolulu heart program). Am J Cardiol. 2003;92:665–9.

    Article  PubMed  CAS  Google Scholar 

  15. Al-Delaimy WK, Rimm EB, Willett WC, Stampfer MJ, Hu FB. Magnesium intake and risk of coronary heart disease among men. J Am Coll Nutr. 2004;23:63–70.

    PubMed  CAS  Google Scholar 

  16. Song Y, Manson JE, Cook NR, Albert CM, Buring JE, Liu S. Dietary magnesium intake and risk of cardiovascular disease among women. Am J Cardiol. 2005;96:1135–41.

    Article  PubMed  CAS  Google Scholar 

  17. Ascherio A, Rimm EB, Giovannucci EL, Colditz GA, Rosner B, Willett WC, et al. A prospective study of nutritional factors and hypertension among us men. Circulation. 1992;86:1475–84.

    Article  PubMed  CAS  Google Scholar 

  18. Song Y, Sesso HD, Manson JE, Cook NR, Buring JE, Liu S. Dietary magnesium intake and risk of incident hypertension among middle-aged and older us women in a 10-year follow-up study. Am J Cardiol. 2006;98:1616–21.

    Article  PubMed  CAS  Google Scholar 

  19. Folsom AR, Hong CP. Magnesium intake and reduced risk of colon cancer in a prospective study of women. Am J Epidemiol. 2006;163:232–5.

    Article  PubMed  Google Scholar 

  20. Larsson SC, Bergkvist L, Wolk A. Magnesium intake in relation to risk of colorectal cancer in women. JAMA. 2005;293:86–9.

    Article  PubMed  CAS  Google Scholar 

  21. Walder RY, Landau D, Meyer P, Shalev H, Tsolia M, Borochowitz Z, et al. Mutation of trpm6 causes familial hypomagnesemia with secondary hypocalcemia. Nat Genet. 2002;31:171–4.

    Article  PubMed  CAS  Google Scholar 

  22. Schlingmann KP, Weber S, Peters M, Niemann Nejsum L, Vitzthum H, Klingel K, et al. Hypomagnesemia with secondary hypocalcemia is caused by mutations in trpm6, a new member of the trpm gene family. Nat Genet. 2002;31:166–70.

    Article  PubMed  CAS  Google Scholar 

  23. Schlingmann KP, Konrad M, Seyberth HW. Genetics of hereditary disorders of magnesium homeostasis. Pediatr Nephrol. 2004;19:13–25.

    Article  PubMed  Google Scholar 

  24. Groenestege WM, Hoenderop JG, van den Heuvel L, Knoers N, Bindels RJ. The epithelial mg2+ channel transient receptor potential melastatin 6 is regulated by dietary mg2+ content and estrogens. J Am Soc Nephrol. 2006;17:1035–43.

    Article  PubMed  CAS  Google Scholar 

  25. Shalev H, Phillip M, Galil A, Carmi R, Landau D. Clinical presentation and outcome in primary familial hypomagnesaemia. Arch Dis Child. 1998;78:127–30.

    Article  PubMed  CAS  Google Scholar 

  26. Takezawa R, Schmitz C, Demeuse P, Scharenberg AM, Penner R, Fleig A. Receptor-mediated regulation of the trpm7 channel through its endogenous protein kinase domain. Proc Natl Acad Sci USA. 2004;101:6009–14.

    Article  PubMed  CAS  Google Scholar 

  27. Montell C. The trp superfamily of cation channels. Sci STKE. 2005;2005:re3.

    Article  PubMed  Google Scholar 

  28. Barbagallo M, Dominguez LJ, Galioto A, Ferlisi A, Cani C, Malfa L, et al. Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome x. Mol Aspects Med. 2003;24:39–52.

    Article  PubMed  CAS  Google Scholar 

  29. Chakraborti S, Chakraborti T, Mandal M, Mandal A, Das S, Ghosh S. Protective role of magnesium in cardiovascular diseases: a review. Mol Cell Biochem. 2002;238:163–79.

    Article  PubMed  CAS  Google Scholar 

  30. Suarez A, Pulido N, Casla A, Casanova B, Arrieta FJ, Rovira A. Impaired tyrosine-kinase activity of muscle insulin receptors from hypomagnesaemic rats. Diabetologia. 1995;38:1262–70.

    Article  PubMed  CAS  Google Scholar 

  31. Paolisso G, Barbagallo M. Hypertension, diabetes mellitus, and insulin resistance: the role of intracellular magnesium. Am J Hypertens. 1997;10:346–55.

    Article  PubMed  CAS  Google Scholar 

  32. Giugliano D, Paolisso G, Ceriello A. Oxidative stress and diabetic vascular complications. Diabetes Care. 1996;19:257–67.

    Article  PubMed  CAS  Google Scholar 

  33. Weglicki WB, Phillips TM, Freedman AM, Cassidy MM, Dickens BF. Magnesium-deficiency elevates circulating levels of inflammatory cytokines and endothelin. Mol Cell Biochem. 1992;110:169–73.

    Article  PubMed  CAS  Google Scholar 

  34. Kurantsin-Mills J, Cassidy MM, Stafford RE, Weglicki WB. Marked alterations in circulating inflammatory cells during cardiomyopathy development in a magnesium-deficient rat model. Br J Nutr. 1997;78:845–55.

    Article  PubMed  CAS  Google Scholar 

  35. Ma J, Folsom AR, Melnick SL, Eckfeldt JH, Sharrett AR, Nabulsi AA, et al. Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: the aric study. Atherosclerosis risk in communities study. J Clin Epidemiol. 1995;48:927–40.

    Article  PubMed  CAS  Google Scholar 

  36. Rosolova H, Mayer O, Reaven GM. Insulin-mediated glucose disposal is decreased in normal subjects with relatively low plasma magnesium concentrations. Metabolism. 2000;49:418–20.

    Article  PubMed  CAS  Google Scholar 

  37. Manolio TA, Savage PJ, Burke GL, Hilner JE, Liu K, Orchard TJ, et al. Correlates of fasting insulin levels in young adults: the cardia study. J Clin Epidemiol. 1991;44:571–8.

    Article  PubMed  CAS  Google Scholar 

  38. Guerrero-Romero F, Tamez-Perez HE, Gonzalez-Gonzalez G, Salinas-Martinez AM, Montes-Villarreal J, Trevino-Ortiz JH, et al. Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial. Diabetes Metab. 2004;30:253–8.

    Article  PubMed  CAS  Google Scholar 

  39. Paolisso G, Sgambato S, Gambardella A, Pizza G, Tesauro P, Varricchio M, et al. Daily magnesium supplements improve glucose handling in elderly subjects. Am J Clin Nutr. 1992;55:1161–7.

    PubMed  CAS  Google Scholar 

  40. Purvis JR, Cummings DM, Landsman P, Carroll R, Barakat H, Bray J, et al. Effect of oral magnesium supplementation on selected cardiovascular risk factors in non-insulin-dependent diabetics. Arch Fam Med. 1994;3:503–8.

    Article  PubMed  CAS  Google Scholar 

  41. Song Y, He K, Levitan EB, Manson JE, Liu S. Effects of oral magnesium supplementation on glycaemic control in type 2 diabetes: a meta-analysis of randomized double-blind controlled trials. Diabet Med. 2006;23:1050–6.

    Article  PubMed  CAS  Google Scholar 

  42. Balon TW, Jasman AP, Scott S, Meehan WP, Rude RK, Nadler JL. Dietary magnesium prevents fructose-induced insulin insensitivity in rats. Hypertension. 1994;23:1036–9.

    Article  PubMed  CAS  Google Scholar 

  43. Balon TW, Gu JL, Tokuyama Y, Jasman AP, Nadler JL. Magnesium supplementation reduces development of diabetes in a rat model of spontaneous NIDDM. Am J Physiol. 1995;269:E745–52.

    PubMed  CAS  Google Scholar 

  44. Kao WH, Folsom AR, Nieto FJ, Mo JP, Watson RL, Brancati FL. Serum and dietary magnesium and the risk for type 2 diabetes mellitus: the atherosclerosis risk in communities study. Arch Intern Med. 1999;159:2151–9.

    Article  PubMed  CAS  Google Scholar 

  45. de Lourdes LM, Cruz T, Carreiro Pousada J, Rodrigues LE, Barbosa K, Canguca V. The effect of magnesium supplementation in increasing doses on the control of type 2 diabetes. Diabetes Care. 1998;21:682–6.

    Article  Google Scholar 

  46. Larsson SC, Wolk A. Magnesium intake and risk of type 2 diabetes: a meta-analysis. J Intern Med. 2007;262:208–14.

    Article  PubMed  CAS  Google Scholar 

  47. Schulze MB, Schulz M, Heidemann C, Schienkiewitz A, Hoffmann K, Boeing H. Fiber and magnesium intake and incidence of type 2 diabetes: a prospective study and meta-analysis. Arch Intern Med. 2007;167:956–65.

    Article  PubMed  CAS  Google Scholar 

  48. Dong JY, Xun P, He K, Qin LQ. Magnesium intake and risk of type 2 diabetes: meta-analysis of prospective cohort studies. Diabetes Care. 2011;34:2116–22.

    Article  PubMed  CAS  Google Scholar 

  49. Dai LJ, Ritchie G, Kerstan D, Kang HS, Cole DE, Quamme GA. Magnesium transport in the renal distal convoluted tubule. Physiol Rev. 2001;81:51–84.

    PubMed  CAS  Google Scholar 

  50. Simon DB, Lu Y, Choate KA, Velazquez H, Al-Sabban E, Praga M, et al. Paracellin-1, a renal tight junction protein required for paracellular mg2+ resorption. Science. 1999;285:103–6.

    Article  PubMed  CAS  Google Scholar 

  51. Voets T, Nilius B, Hoefs S, van der Kemp AW, Droogmans G, Bindels RJ, et al. Trpm6 forms the mg2+ influx channel involved in intestinal and renal mg2+ absorption. J Biol Chem. 2004;279:19–25.

    Article  PubMed  CAS  Google Scholar 

  52. Nilius B, Voets T, Peters J. Trp channels in disease. Sci STKE. 2005;2005:re8.

    Article  PubMed  Google Scholar 

  53. Li M, Jiang J, Yue L. Functional characterization of homo- and heteromeric channel kinases trpm6 and trpm7. J Gen Physiol. 2006;127:525–37.

    Article  PubMed  CAS  Google Scholar 

  54. Schmitz C, Dorovkov MV, Zhao X, Davenport BJ, Ryazanov AG, Perraud AL. The channel kinases trpm6 and trpm7 are functionally nonredundant. J Biol Chem. 2005;280:37763–71.

    Article  PubMed  CAS  Google Scholar 

  55. Schlingmann KP, Sassen MC, Weber S, Pechmann U, Kusch K, Pelken L, et al. Novel trpm6 mutations in 21 families with primary hypomagnesemia and secondary hypocalcemia. J Am Soc Nephrol. 2005;16:3061–9.

    Article  PubMed  Google Scholar 

  56. Chubanov V, Waldegger S, Mederos y Schnitzler M, Vitzthum H, Sassen MC, Seyberth HW, et al. Disruption of trpm6/trpm7 complex formation by a mutation in the trpm6 gene causes hypomagnesemia with secondary hypocalcemia. Proc Natl Acad Sci USA. 2004;101:2894–9.

    Article  PubMed  CAS  Google Scholar 

  57. Wolf FI. Trpm7: channeling the future of cellular magnesium homeostasis? Sci STKE. 2004;2004:pe23.

    Article  PubMed  Google Scholar 

  58. Jiang J, Li M, Yue L. Potentiation of trpm7 inward currents by protons. J Gen Physiol. 2005;126:137–50.

    Article  PubMed  CAS  Google Scholar 

  59. Demeuse P, Penner R, Fleig A. Trpm7 channel is regulated by magnesium nucleotides via its kinase domain. J Gen Physiol. 2006;127:421–34.

    Article  PubMed  CAS  Google Scholar 

  60. Schmitz C, Perraud AL, Johnson CO, Inabe K, Smith MK, Penner R, et al. Regulation of vertebrate cellular mg2+ homeostasis by trpm7. Cell. 2003;114:191–200.

    Article  PubMed  CAS  Google Scholar 

  61. Weber S, Schlingmann KP, Peters M, Nejsum LN, Nielsen S, Engel H, et al. Primary gene structure and expression studies of rodent paracellin-1. J Am Soc Nephrol. 2001;12:2664–72.

    PubMed  CAS  Google Scholar 

  62. Hou J, Paul DL, Goodenough DA. Paracellin-1 and the modulation of ion selectivity of tight junctions. J Cell Sci. 2005;118:5109–18.

    Article  PubMed  CAS  Google Scholar 

  63. Kausalya PJ, Amasheh S, Gunzel D, Wurps H, Muller D, Fromm M, et al. Disease-associated mutations affect intracellular traffic and paracellular mg2+ transport function of claudin-16. J Clin Invest. 2006;116:878–91.

    Article  PubMed  CAS  Google Scholar 

  64. Wabakken T, Rian E, Kveine M, Aasheim HC. The human solute carrier slc41a1 belongs to a novel eukaryotic subfamily with homology to prokaryotic mgte mg2+ transporters. Biochem Biophys Res Commun. 2003;306:718–24.

    Article  PubMed  CAS  Google Scholar 

  65. Goytain A, Quamme GA. Functional characterization of human slc41a1, a mg2+ transporter with similarity to prokaryotic mgte mg2+ transporters. Physiol Genomics. 2005;21:337–42.

    Article  PubMed  CAS  Google Scholar 

  66. Kolisek M, Zsurka G, Samaj J, Weghuber J, Schweyen RJ, Schweigel M. Mrs2p is an essential component of the major electrophoretic mg2+ influx system in mitochondria. EMBO J. 2003;22:1235–44.

    Article  PubMed  CAS  Google Scholar 

  67. Zsurka G, Gregan J, Schweyen RJ. The human mitochondrial mrs2 protein functionally substitutes for its yeast homologue, a candidate magnesium transporter. Genomics. 2001;72:158–68.

    Article  PubMed  CAS  Google Scholar 

  68. Wilson FH, Hariri A, Farhi A, Zhao H, Petersen KF, Toka HR, et al. A cluster of metabolic defects caused by mutation in a mitochondrial trna. Science. 2004;306:1190–4.

    Article  PubMed  CAS  Google Scholar 

  69. Sweadner KJ, Wetzel RK, Arystarkhova E. Genomic organization of the human fxyd2 gene encoding the gamma subunit of the na, k-atpase. Biochem Biophys Res Commun. 2000;279:196–201.

    Article  PubMed  CAS  Google Scholar 

  70. Geering K. Fxyd proteins: new regulators of na-k-atpase. Am J Physiol Renal Physiol. 2006;290:F241–50.

    Article  PubMed  CAS  Google Scholar 

  71. Meij IC, Koenderink JB, van Bokhoven H, Assink KF, Groenestege WT, de Pont JJ, et al. Dominant isolated renal magnesium loss is caused by misrouting of the na(+), k(+)-atpase gamma-subunit. Nat Genet. 2000;26:265–6.

    Article  PubMed  CAS  Google Scholar 

  72. Gamba G, Saltzberg SN, Lombardi M, Miyanoshita A, Lytton J, Hediger MA, et al. Primary structure and functional expression of a cdna encoding the thiazide-sensitive, electroneutral sodium-chloride cotransporter. Proc Natl Acad Sci USA. 1993;90:2749–53.

    Article  PubMed  CAS  Google Scholar 

  73. Mastroianni N, Bettinelli A, Bianchetti M, Colussi G, De Fusco M, Sereni F, et al. Novel molecular variants of the na-cl cotransporter gene are responsible for Gitelman syndrome. Am J Hum Genet. 1996;59:1019–26.

    PubMed  CAS  Google Scholar 

  74. Simon DB, Nelson-Williams C, Bia MJ, Ellison D, Karet FE, Molina AM, et al. Gitelman’s Variant of Bartter’s syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive na-cl cotransporter. Nat Genet. 1996;12:24–30.

    Article  PubMed  CAS  Google Scholar 

  75. Takeuchi K, Kure S, Kato T, Taniyama Y, Takahashi N, Ikeda Y, et al. Association of a mutation in thiazide-sensitive na-cl cotransporter with familial Gitelman’s syndrome. J Clin Endocrinol Metab. 1996;81:4496–9.

    Article  PubMed  CAS  Google Scholar 

  76. Song Y, Hsu YH, Niu T, Manson JE, Buring JE, Liu S. Common genetic variants of the ion channel transient receptor potential membrane melastatin 6 and 7 (trpm6 and trpm7), magnesium intake, and risk of type 2 diabetes in women. BMC Med Genet. 2009;10:4.

    Article  PubMed  Google Scholar 

  77. De Silva NM, Frayling TM. Novel biological insights emerging from genetic studies of type 2 diabetes and related metabolic traits. Curr Opin Lipidol. 2010;21:44–50.

    Article  PubMed  Google Scholar 

  78. Meyer TE, Verwoert GC, Hwang SJ, Glazer NL, Smith AV, van Rooij FJ, et al. Genome-wide association studies of serum magnesium, potassium, and sodium concentrations identify six loci influencing serum magnesium levels. PLoS Genet. 2010;6:e1001045.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yiqing Song M.D., Sc.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Song, Y., Zhang, C., Wang, L., Dai, Q., Liu, S. (2013). Magnesium Intake, Genetic Variants, and Diabetes Risk. In: Watson, R., Preedy, V., Zibadi, S. (eds) Magnesium in Human Health and Disease. Nutrition and Health. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-044-1_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-62703-044-1_6

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-62703-043-4

  • Online ISBN: 978-1-62703-044-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics